Search the site
Nick Kawar
Associate
Nick Kawar practices exclusively in the area of intellectual property law. Prior to joining Sprigings IP, he gained experience in intellectual property litigation and trademark prosecution at a boutique firm in Toronto. Nick received his J.D. Degree from the University of Windsor Law School in 2017, where he also worked as a research assistant in copyright law and volunteered at the International Intellectual Property Law Clinic in Detroit. Before attending law school, Nick obtained an Honours Bachelor of Science from York University in Biology and Psychology.
Education
- B.Sc., York University
- J.D., University of Windsor
Bar Admission
- Ontario, 2017
Professional Involvement
- Member, Canadian Bar Association
- Member, Ontario Bar Association
Recent Cases
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,791,171 (apixaban)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,461,202 (apixaban)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,762,013 and 2,620,380 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,937,365 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,620,380 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,631,646 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,667,654 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,709,997 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,710,014 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,710,358 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,819,967 (pirfenidone)
Interlocutory appeal in a patent impeachment action relating to Patent No. 2,261,630 (infliximab)
Appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)
Patent impeachement and patent infringement case regarding Patent No. 2,261,630 (infliximab).
More people
